Individuals Coming Off Slimming Injections Regain Pounds Far More Rapidly Compared to Dieters

A recent study indicates that people who stop using popular weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who end traditional diet and exercise plans.

Published data in a leading medical journal points out that while obese individuals often shed a large proportion of their body weight while on the medication, the weight is regained at an average rate of 0.8 kg per month once they quit.

"Users using such treatments need to be aware of the danger of rapid weight regain when the medication concludes," stated researcher Dr. Susan Jebb.

That rate of recovery suggests a return to pre-treatment mass within about 18 months.

Weighing Therapies

The analysis, which examined dozens of trials involving over 9,000 of participants, contrasted the outcomes of the injectable medications with conventional dieting.

The team note that individuals who lose weight through lifestyle changes alone usually experience a more gradual weight regain—perhaps 100 grams monthly—once they finish.

Explaining the Quick Rebound

Experts propose the way of the drugs explains the accelerated regain.

The injections copy a natural hormone called glucagon-like peptide-1, which controls appetite.

"Sustained high doses of GLP-1 levels several times higher than normal could lead to the system to generate a reduced amount of its endogenous hormone, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.

"Stopping of this GLP-1 'fix' means appetite is unsuppressed, making excessive eating much more probable."

A Lifelong Condition?

The NHS suggest the jabs for individuals with weight-linked health risks, accompanied by recommended lifestyle changes.

A number of clinicians say that, considering the significant potential of relapse, the treatment might need to be long-term.

This opinion is supported by drug manufacturers, who note that the findings "highlight the long-term character of excess weight," similar to managing diseases like diabetes.

User Accounts

Individuals who have stopped the jabs explain a sudden return of hunger.

"It felt as if a switch activating and you're instantly starving," said a patient.

This difficulty is compounded if patients have not established sustainable dietary or behavioural modifications during treatment.

Significant Use

Figures suggest that millions of adults in the UK have used these injections in the past year, with desire continuing to grow.

• Use is more common among women compared to men.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion access the drugs through private prescriptions rather than public health services.

In conclusion, researchers stress that while these medications are potent agents for shedding pounds, they are not a standalone solution and long-term success hinges on integrated behavioural changes.